Clonal Evolution and Somatic Reversion in Genetic Predisposition to TP53-Mutated MDS
Original lecture date: February 17, 2022
Akiko Shimamura, MD, PhD
Professor of Pediatrics, Harvard Medical School
Samuel E. Lux IV Chair in Hematology Oncology
Director, Bone Marrow Failure and MDS Program
Dana Farber/Boston Children’s Cancer and Blood Disorders Center